Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVTX | Common Stock | Small acquisition under Rule 16a-6 | $1.32K | +334 | +0.01% | $3.95* | 3.97M | Feb 3, 2023 | See Footnote | F1, F2 |
transaction | AVTX | Common Stock | Purchase | +450K | +11.35% | 4.42M | Feb 7, 2023 | See Footnote | F1, F2, F3 | ||
holding | AVTX | Common Stock | 34.4K | Feb 3, 2023 | Direct | F1, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVTX | Warrant | Purchase | +450K | 450K | Feb 7, 2023 | Common Stock | 450K | $5.00 | See Footnote | F1, F2, F4 |
Id | Content |
---|---|
F1 | This amount reflects the effect of the 1-for-12 reverse stock split. |
F2 | The reported securities of Avalo Therapeutics, Inc. (the "Issuer") are directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the "Master Fund"), and may be deemed to be indirectly beneficially owned by: (i) Armistice Capital, LLC ("Armistice Capital"), as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital ("Mr. Boyd", and collectively with the Master Fund and Armistice Capital, the "Reporting Persons"). Each of Armistice Capital and Mr. Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
F3 | Each share of common stock and accompanying warrant were purchased together for $3.98. The warrants are subject to a 4.99% beneficial ownership limitation on exercise. |
F4 | These shares are directly owned by Mr. Boyd in his personal capacity. |